---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-001284"
form_type: "8-K"
ticker: "ATR"
cik: "0000896622"
company_name: "APTARGROUP, INC."
filed_at: "2021-10-28T23:59:59+00:00"
generated_at: "2026-06-28T17:09:30.519967+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AptarGroup Q3 revenue $825M (+9% YoY); adjusted EPS $0.94 vs $1.01; guides Q4 $0.88-$0.96

## Summary
- Reported sales $825M, +9% YoY; core sales +8%; Pharma core -2%, Beauty+Home +10%, Food+Beverage +28%.
- Reported EPS $0.70 (includes $0.12 restructuring, $0.10 unrealized loss on PureCycle investment, $0.02 acquisition costs); adjusted EPS $0.94.
- Adjusted EBITDA $154M; net income $47M.
- Completed acquisitions: 80% of Weihai Hengyu Medical Products and majority stake in Voluntis.
- Q4 2021 adjusted EPS guidance $0.88-$0.96; quarterly dividend $0.38/share payable Nov 17, 2021.

## SEC filing metadata
- accession: 0001157523-21-001284
- form_type: 8-K
- ticker: ATR
- cik: 0000896622
- company_name: APTARGROUP, INC.
- filed_at: 2021-10-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896622/000115752321001284/0001157523-21-001284-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896622/000115752321001284/a52517971.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-001284
- JSON: https://secwatch.observer/filing/0001157523-21-001284.json
- Plain text: https://secwatch.observer/filing/0001157523-21-001284.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.